Aclaris Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
04 Mar 24 | Buy€16,531 | Andrew Kenneth Powell | Individual | 14,500 | €1.15 | |
06 Sep 23 | Buy€69,963 | Kevin Balthaser | Individual | 9,490 | €7.37 | |
28 Aug 23 | Buy€92,512 | James Loerop | Individual | 14,705 | €6.29 |
Insider Trading Volume
Insider Buying: 8AT insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 9,744 | 0.0137% |
General Public | 936,977 | 1.31% |
Individual Insiders | 1,972,838 | 2.77% |
Hedge Funds | 18,554,649 | 26% |
Institutions | 49,790,578 | 69.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,395,934 | €10.7m | 1,340% | 7.78% | |||
5,905,872 | €6.7m | 5.31% | no data | |||
5,388,789 | €6.1m | 60.5% | 0.01% | |||
4,722,357 | €5.4m | 40.4% | no data | |||
3,769,926 | €4.3m | 8.35% | no data | |||
3,500,000 | €4.0m | 2.94% | 0.4% | |||
2,998,495 | €3.4m | -24.3% | 0.1% | |||
2,351,407 | €2.7m | 0% | 0.01% | |||
1,939,010 | €2.2m | 2,840% | no data | |||
1,761,595 | €2.0m | 0% | 1.3% | |||
1,753,335 | €2.0m | 0% | 0.24% | |||
1,746,432 | €2.0m | 170% | no data | |||
1,679,905 | €1.9m | 0% | no data | |||
1,587,995 | €1.8m | 4,080% | 0.17% | |||
1,463,461 | €1.7m | 5,550% | no data | |||
1,421,000 | €1.6m | 873% | no data | |||
1,393,548 | €1.6m | 4.22% | no data | |||
1,388,439 | €1.6m | -11.1% | no data | |||
1,285,688 | €1.5m | 0.98% | no data | |||
979,399 | €1.1m | 0% | 0.42% | |||
934,046 | €1.1m | 505% | no data | |||
921,585 | €1.0m | -42.6% | no data | |||
748,775 | €849.2k | 327% | no data | |||
696,171 | €789.6k | 0% | 0.17% | |||
670,714 | €760.7k | 1.42% | no data |